Home About News

News & Announcements

  < 1 | 2 | 3 | 4 | 5  > 
Update: Important Message About FDA Statement on MUS

posted: April 25, 2019
On April 16, 2019, the U.S. Food and Drug Administration (FDA) issued an unexpected mandate recalling and halting the distribution of all remaining surgical mesh indicated for transvaginal (TV) repair of pelvic organ prolapse (POP), effective immediately.

View Details

SUFU Update on FDA meeting

posted: February 15, 2019
On February 12th 2019, the FDA convened a meeting of the Obstetrics and Gynecology Medical Device Advisory Committee in Washington, D.C. to specifically address the safety and effectiveness of surgical mesh for transvaginal repair of pelvic organ prolapse in the anterior vaginal compartment.

View Details

UPDATED: SUFU MUS Position Statement

posted: February 12, 2019
SUFU Position Statement on Mesh Midurethral Slings (MUS) for Stress Urinary Incontinence (Updated February 2019)

View Details

New Online Course for Urology Researchers Seeking NIH Funding

posted: December 3, 2018
The AUA’s “Writing A Successful Career Development Award Application” course is written by NIH-funded urology researchers and will help prepare early-career investigators to write competitive grant applications.

View Details

SUFU Statement Regarding FDA Communication on “Vaginal Rejuvenation”:

posted: August 7, 2018
On July 30, 2018, the FDA posted a communication regarding the use of energy-based devices, including laser and radiofrequency, for vaginal cosmesis and “rejuvenation.”

View Details

  < 1 | 2 | 3 | 4 | 5  >